Insider Transactions in Q4 2023 at Entrada Therapeutics, Inc. (TRDA)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 26
2023
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
94
-0.19%
|
$1,504
$16.67 P/Share
|
|
Dec 26
2023
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
94
+0.19%
|
$188
$2.1 P/Share
|
|
Dec 22
2023
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,206
-8.91%
|
$153,090
$15.86 P/Share
|
|
Dec 22
2023
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,206
+14.58%
|
$20,412
$2.1 P/Share
|
|
Dec 21
2023
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,200
-4.25%
|
$33,000
$15.07 P/Share
|
|
Dec 21
2023
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+4.08%
|
$4,400
$2.1 P/Share
|
|
Dec 20
2023
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.41%
|
$15,000
$15.0 P/Share
|
|
Nov 13
2023
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.4%
|
$16,000
$16.23 P/Share
|
|
Oct 17
2023
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.4%
|
$15,000
$15.0 P/Share
|